|
|
Other links at Articles > Hematology-Oncology |
| 5. |
Continuation Maintenance Therapy in Patients With NSCLC
|
|
|
Continuation maintenance therapy consists of extending initial therapy until disease progression. Dr. Mark Kris reviews the best evidence for regimens including cetuximab, bevacizumab, and erlotinib. Medscape Hematology-Oncology
|
|
|